Genelux (GNLX) Net Cash Flow (2022 - 2026)
Genelux (GNLX) posted Net Cash Flow of $3.9 million for Q1 2026, up 509.22% on a QoQ basis from $640000.0 in Q4 2025, and down 48.97% year-over-year from $7.6 million in Q1 2025.
Analysis
Genelux (GNLX) Net Cash Flow (2022 - 2026) Analysis & Trends
Genelux has reported Net Cash Flow for 5 years, with the latest figure at $3.9 million in Q1 2026.
- On a quarterly basis, Net Cash Flow fell 48.97% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was -$7.0 million, a 157.69% decrease from a year earlier, with the FY2025 full-year figure at -$3.3 million, down 282.65% from the prior year.
- Net Cash Flow was $3.9 million for Q1 2026 at Genelux, up from $640000.0 in the prior quarter.
- The five-year high for Net Cash Flow was $16.8 million in Q2 2023, with the low at -$20.5 million in Q4 2023.
- Average Net Cash Flow over 5 years is $700666.7, with a median of $2.5 million recorded in 2024.
- The largest YoY upside for Net Cash Flow was 270.93% in 2023 against a maximum downside of 2001.85% in 2023.
- Over 5 years, Net Cash Flow stood at -$973000.0 in 2022, then tumbled by 2001.85% to -$20.5 million in 2023, then soared by 112.04% to $2.5 million in 2024, then sank by 74.02% to $640000.0 in 2025, then surged by 509.22% to $3.9 million in 2026.
- The last three Net Cash Flow figures came in at $3.9 million (Q1 2026), $640000.0 (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1.95 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -4.43 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 652.90 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -504.30 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -183.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -496,000.00 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -2.09 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -170.75 Mn |
| 10 | Genelux | 108.17 Mn | 108.17 Mn | - | 3.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.90 Mn |
| Dec 31, 2025 | 640,000.00 |
| Sep 30, 2025 | -1.88 Mn |
| Jun 30, 2025 | -9.67 Mn |
| Mar 31, 2025 | 7.64 Mn |
| Dec 31, 2024 | 2.46 Mn |
| Sep 30, 2024 | -1.76 Mn |
| Jun 30, 2024 | 3.80 Mn |
| Mar 31, 2024 | -5.36 Mn |
| Dec 31, 2023 | -20.45 Mn |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | 16.80 Mn |
| Mar 31, 2023 | 9.94 Mn |
| Dec 31, 2022 | -973,000.00 |
| Mar 31, 2022 | 2.68 Mn |